Journavx is designed to eliminate the risks of addiction and overdose associated with medications like Vicodin and OxyContin.

The Health and Human Services Office of Inspector General has found that, in a few cases, FDA officials veered from the accelerated approval pathway.

The Food and Drug Administration’s approval of low-risk tobacco pouches is welcome, but why did it delay for more than four ...

The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.

Vertex has gained the FDA's approval for its non-addictive pain med Journavx, which becomes the first significant innovation ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

Patented genetics from Charlotte’s Web were used in the process. There are very rare instances when cannabis-based drug candidates have achieved FDA approval, with only one containing cannabis ...

Robert F. Kennedy Jr. may soon be America's top pharmaceutical regulator. That is cause for concern in Seattle’s biotech ...

The decision builds on previous FDA approval for the drug’s treatment when combined ... Spravato’s approval through its Priority Review process after receiving results from a randomized ...

A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the ...

The new indications, approved Tuesday by the FDA, make Ozempic the most broadly indicated drug in its class ... clinicians with their decision-making process, and it helps them focus those ...

Federal regulators have warned a Waco company that its human amniotic products are “unlicensed” and “unapproved,” and that ...